Treatment of HIV-Infected Individuals with the Histone Deacetylase Inhibitor Panobinostat Results in Increased Numbers of Regulatory T Cells and Limits Ex Vivo Lipopolysaccharide-Induced Inflammatory Responses.
Brinkmann CR, H?jen JF, Rasmussen TA, Kj?r AS, Olesen R, Denton PW, ?stergaard L, Ouyang Z, Lichterfeld M, Yu X, S?gaard OS, Dinarello C, Tolstrup M. Treatment of HIV-Infected Individuals with the Histone Deacetylase Inhibitor Panobinostat Results in Increased Numbers of Regulatory T Cells and Limits Ex Vivo Lipopolysaccharide-Induced Inflammatory Responses. mSphere. 2018 Jan-Feb; 3(1).